Benzodiazepines (BZPs) are widely used as anxiolytic drugs, and we have previously demonstrated that diazep am (DZP), an anxiolytic agent acting on BZP receptors, inhibits the psychological-stress-induced analgesia (PSY SIA) dose-dependently (1, 2) and 19-carboline-3-carboxyl ic acid ethyl ester, an inverse agonist on BZP receptors, potentiates the PSY-SIA (2). Likewise, we have found that concurrent exposure to PSY stress blocks the develop ment of antinociceptive tolerance to morphine, and the effect of PSY-stress is reversed by DZP, indicating the in volvement of emotional factors such as anxiety, fear and unpleasantness, which are mediated through BZP recep tors in the production of PSY-SIA (2).
It is well known that administration of BZPs is often ac companied by undesirable side effects such as drowsiness, ataxia and sedation. Bcause of the discovery of the anti anxiety action of buspirone, a partial agonist of serotonin (5-HT)IA receptors, that is devoid of side effects of BZPs (3, 4), the importance of 5-HTnergic mechanisms for the control of anxiety is now being realized. In addition, BZPs are known to reduce 5-HT turnover and decrease the activity of the central 5-HT neurons (5), suggesting the interaction between the BZP and the 5-HT system. The present study was carried out to clarify the involve ment of the 5-HT receptor-mediated mechanisms in the production of PSY-SIA, using typical compounds selec tive for the 5-HT receptor subtypes.
MATERIALS AND METHODS

Animals
Male mice of the ddY strain weighing 18 20 g (Otsubo Exp. Animals, Nagasaki) were purchased and housed as a group of 20 animals. They were maintained in an ambient temperature (22±1°C) and relative humidity (55-L5%) controlled room with free access to laboratory diet (MF, Oriental Yeast, Tokyo) and tap water. After reaching 23 to 28 g, they were used for the experiments.
Drugs and administration schedules
Morphine-hydrochloride (Takeda Pharm. Co., Osaka) and methysergide maleate, a 5-HT receptor antagonist (U.S.P.C., Inc., Rockville, MD, USA) were commercial ly obtained. The following drugs were generously donat ed: buspirone-hydrochloride, a 5-HTIA receptor partial agonist (Bristol-Myers Co., Evansville, IN, USA); (±)pin dolol, a 5-HT,A,1B receptor antagonist (Sandoz, Berne, Switzerland); ritanserin tartrate, a 5-HT2 receptor an tagonist (Janssen-Kyowa Pharm. Co., Tokyo) and Y 25,130 ((±)N--(1-azabicyclo[2,2,2]oct-3-yl)-6-chloro-4 methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-8-carbox amide hydrochloride), a 5-HT3 receptor antagonist (Yoshitomi Pharm. Co., Fukuoka). Methysergide was dissolved in 25% polyethylene glycol, and ritanserin was ultrasonically dispersed in 10% dimethyl sulfoxide. Other drugs were dissolved in saline. They were administered i.p. in a volume of 0.1 ml/10 g of body weight, and the dose was expressed in terms of the respective salt.
Morphine and other drugs were injected 15 min and 30 min, respectively, before exposure to PSY-stress.
Exposure to PSY-stress
Using the communication box with a slight modifica tion of the method of Ogawa and Kuwahara (6), animals were exposed to PSY-stress by watching and hearing the struggle, jumping and vocalization of the footshocked animals for 5 min. The protocol and techniques for ex posure to PSY-stress were described in our previous report (7).
Assessment of antinociceptive effect
The antinociceptive effect was measured by the modified Haffner's method (8), which is a tail pinch test (TP), with a cutoff time of 6 sec to avoid any damage to the tail, every 5 min from immediately after the termina tion of the stress exposure for 15 min or every 15 min af ter the administration of morphine for a period of 90 min. In the case of concurrent exposure to PSY-stress with morphine, the 1st measurement was performed at 20 min after the morphine injection.
Evaluation of morphine tolerance
Injection of morphine at the dose of 10 mg/kg, i.p. was repeated daily for 5 days. The effect was expressed as the area under the curve (AUC) obtained by plotting the in crease in response time (sec) on the ordinate and the time intervals (min) on the abscissa. A significant decrease of AUC, compared with that of the 1st day, indicated the de velopment of tolerance.
Statistical analyses
The results were expressed as the mean ±S.E. Follow ing analysis of variance for repeated measures of the over all data to assess statistical significance, differences be tween the individual mean values in different groups were analyzed by Dunnett's test. A difference was considered siginificant at P < 0.05 . (Fig. 1) .
Ritanserin at the doses of 1.0 to 5.0 mg/kg or Y-25,130 at the doses of 0.03 and 0.1 mg/kg inhibited PSY-SIA dose dependently, while (± )pindolol was ineffective at doses up to 3.0 mg/kg (Fig. 2) . Throughout the experiments, these drugs at the doses employed here did not affect the response time before the exposure to PSY-stress (data not shown).
Effect of methysergide, buspirone, (±)pindolol, ritan serin and Y-25,130 on the blockade by PSY-stress of the development of morphine tolerance Daily injection of morphine at 10 mg/kg developed tolerance to its antinociceptive effect, and the effect was remarkably reduced by 5 repetitions. Concurrent expo sure to PSY-stress completely suppressed the develop ment of antinociceptive tolerance to morphine, and the suppressive effect was antagonized by methysergide at 2.0 mg/kg; buspirone at 1.0 or 3.0 mg/kg (Fig. 3) ; ritanserin at 1.0 and 2.0 mg/kg; and Y-25,130 at 0.03 and 0.1 mg/kg. However, (± )pindolol at doses up to 3.0 mg/kg did not reverse the suppressive effect of PSY-stress (Fig.   4) . Such a pretreatment with these drugs had no effect on the morphine antinociception and its tolerance develop ment (data not shown). 
DISCUSSION
In a series of studies, we found that in the production of PSY-SIA, various receptor-mediated systems such as opioid (7, 9), catecholamine (10), BZP (1, 2) and GABA (11) are involved. Based on these findings, in this study, the participation of 5-HTnergic mechanisms was exam ined using drugs selective for the 5-HT receptor subtypes.
It is reported that buspirone, a 5-HTIA receptor partial agonist, produces an anxiolytic effect in several anxiety model animals (12-14). Complete inhibition of PSY-SIA by buspirone at doses of 3.0 and 10 mg/kg indicates the participation of 5-HT1A receptors in the production of PSY-SIA. Buspirone, however, possesses appreciable af finity for dopamine D2-receptors as well as 5-HTIA recep tors, and consequently, the involvement of dopamine D2 receptors in the production of PSY-SIA could not be neglected (15, 16).
It is well known that (±)pindolol has an antagonistic activity on 5-HTIA and 5-HT,B receptors in addition to j3 adrenoceptors (17, 18). In this experiment, PSY-SIA was not affected by (±)pindolol.
Failure of (±)pindolol to suppress PSY-SIA suggest that 5-HT,B receptors have little importance in the mediation of PSY-SIA in contrast to 5-HT1A receptors and, possibly, that (±)pindolol and buspirone act on 5-HT1A receptors in a different manner.
Ritanserin has been characterized as a potent and long acting central 5-HT2 receptor antagonist (19). As regards to its antianxiety effect, however, no distinct conclusion has been reached (20-23). In the present study, ritanserin showed an apparent suppressive action on PSY-SIA. Therefore, it is suggested that 5-HT2 receptors partici pates in the production of PSY-SIA in addition to 5-HT1A receptors. Although Rodgers et al. (23) Vonvoigtlander et al. (27) and Ho and Takemori (28) have shown that 5-HTnergic mechanisms participate in the production of antinociception by U-50,488H, a x opioid receptor agonist. Our previous reports (7, 9) re vealed that PSY-SIA involved the mediation by K-opioid receptor mechanisms, and in this experiment, we showed that 5-HTnergic-mediated mechanisms were also involved in PSY-SIA. Taken together, it is suggested that both 5 HTnergic mechanisms and x-opioid receptor-mediated mechanisms are closely related to each other for the production of PSY-SIA.
On the other hand, we have shown that concurrent ex posure to PSY-stress blocked the development of anti nociceptive tolerance to morphine, and the suppressive effect was antagonized by DZP (2). Expectantly, the sup pressive effect of PSY-stress on the development of mor phine tolerance was reversed by methysergide, buspirone, ritanserin and Y-25,130 but not by (±)pindolol. Further suggesting the relationship between 5-HT receptors and PSY-SIA, Yamamoto et al. (29) have reported that the de velopment of tolerance to morphine is blocked by the con comitant treatment with U-50,488H. Thus, not only 5 HTnergic but also x-opioid receptor-mediated mecha nisms may underlie the stress effect on the tolerance de velopment.
Recently, 5-HT receptors have been classified into four subtypes, 5-HT1, 5-HT2, 5-HT3 and 5-HT4 receptors. Fur thermore, the 5-HT, receptors can be divided into four distinct subtypes, 5-HT1A, 5-HT1B, 5-HT1c and 5-HTID receptors (30) (31) (32) (33) 
